Current challenges in Barrett's esophagus

ABSTRACT

Barrett’s esophagus, a risk factor for esophageal adenocarcinoma, often goes undetected because it has no defining symptoms that distinguish it from gastroesophageal reflux disease (GERD). Yet early recognition is crucial, and development of reliable, cost-effective surveillance methods must be a public health priority. Several promising techniques could lead to more effective prevention, identification, and management of this premalignant lesion.